IL18 and systemic sclerosis: In bleomycin (BLM)-induced SSc mice, upregulation of IL-1β and IL-18 could be detected in serum and lung tissue, and alleviated disease performance could be found when NLRP3, ASC, or caspase-1 genes were knocked out [61, 62].